[1] TAKAHASHI A, DE ANDRES MC, HASHIMOTO K, et al. Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1946-1954.
[2] LIN D, CHAI Y, MA Y, et al. Rapid initiation of guided bone regeneration driven by spatiotemporal delivery of IL-8 and BMP-2 from hierarchical MBG-based scaffold. Biomaterials. 2019;196:122-137.
[3] RUSSO RC, GARCIA CC, TEIXEIRA MM, et al. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(5):593-619.
[4] HONG L, SHARP T, KHORSAND B, et al. MicroRNA-200c Represses IL-6, IL-8, and CCL-5 Expression and Enhances Osteogenic Differentiation. PLoS One. 2016;11(8): e0160915.
[5] LIU P, LEE S, KNOLL J, et al. Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis. Cell Death Differ. 2017;24(4):672-682.
[6] CHEN X, WANG Z, DUAN N, et al. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99-107.
[7] KIM JM, LIN C, STAVRE Z, et al. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020;9(9):2073.
[8] BENDRE MS, MONTAGUE DC, PEERY T, et al. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone. 2003;33(1):28-37.
[9] YOSHIMURA T. Discovery of IL-8/CXCL8 (The Story from Frederick). Front Immunol. 2015;6:278.
[10] KIM SJ, UEHARA H, KARASHIMA T, et al. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia. 2001;3(1):33-42.
[11] YANG A, LU Y, XING J, et al. IL-8 Enhances Therapeutic Effects of BMSCs on Bone Regeneration via CXCR2-Mediated PI3k/Akt Signaling Pathway. Cell Physiol Biochem. 2018;48(1):361-370.
[12] LI A, DUBEY S, VARNEY ML, et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003;170(6):3369-3376.
[13] LIU MM, DONG R, HUA Z, et al. Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis. Biosci Rep. 2020;40(9):BSR20201778.
[14] SINGH B, BERRY JA, VINCENT LE, et al. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer. J Surg Res. 2006;134(1):44-51.
[15] WANG L, LI Y, ZHANG X, et al. Paracrine interleukin-8 affects mesenchymal stem cells through the Akt pathway and enhances human umbilical vein endothelial cell proliferation and migration. Biosci Rep. 2021;41(5):BSR20210198.
[16] GUO Y, ZANG Y, LV L, et al. IL‑8 promotes proliferation and inhibition of apoptosis via STAT3/AKT/NF‑κB pathway in prostate cancer. Mol Med Rep. 2017;16(6):9035-9042.
[17] WEN J, ZHAO Z, HUANG L, et al. IL-8 promotes cell migration through regulating EMT by activating the Wnt/β-catenin pathway in ovarian cancer. J Cell Mol Med. 2020;24(2):1588-1598.
[18] TOOSI S, BEHRAVAN N, BEHRAVAN J. Nonunion fractures, mesenchymal stem cells and bone tissue engineering. J Biomed Mater Res A. 2018;106(9):2552-2562.
[19] CIUFFI S, ZONEFRATI R, BRANDI ML. Adipose stem cells for bone tissue repair. Clin Cases Miner Bone Metab. 2017;14(2):217-226.
[20] LIU H, LI D, ZHANG Y, et al. Inflammation, mesenchymal stem cells and bone regeneration. Histochem Cell Biol. 2018;149(4):393-404.
[21] KANG KW, LEE SJ, KIM JH, et al. Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization. BMC Cancer. 2020;20(1):619.
[22] BRITSCHGI A, RADIMERSKI T, BENTIRES-ALJ M. Targeting PI3K, HER2 and the IL-8/JAK2 axis in metastatic breast cancer: Which combination makes the whole greater than the sum of its parts? Drug Resist Updat. 2013;16(3-5):68-72.
[23] DOWNWARD J. PI3-kinase, Akt and cell survival. Semin Cell Dev Biol. 2004;15(2): 177-182.
[24] SHEN L, ZHANG S, ZHANG X, et al. Enhancing the ability of autophagy and proliferation of bone marrow mesenchymal stem cells by interleukin-8 through Akt-STAT3 pathway in hypoxic environment. Sheng Wu Gong Cheng Xue Bao. 2016; 32(10):1422-1432.
[25] UCCELLI A, MORETTA L, PISTOIA V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726-736.
[26] PONZETTI M, RUCCI N. Osteoblast Differentiation and Signaling: Established Concepts and Emerging Topics. Int J Mol Sci. 2021;22(13):6651.
[27] NIU X, CHEN Y, QI L, et al. Hypoxia regulates angeogenic-osteogenic coupling process via up-regulating IL-6 and IL-8 in human osteoblastic cells through hypoxia-inducible factor-1α pathway. Cytokine. 2019;113:117-127.
[28] DA CRUZ MB, MARQUES JF, FERNANDES BF, et al. Laser surface treatment on Yttria-stabilized zirconia dental implants: Influence on cell behavior. J Biomed Mater Res B Appl Biomater. 2022;110(1):249-258.
[29] CAI L, LIN D, CHAI Y, et al. MBG scaffolds containing chitosan microspheres for binary delivery of IL-8 and BMP-2 for bone regeneration. J Mater Chem B. 2018;6(27): 4453-4465.
[30] AMARASEKARA DS, YUN H, KIM S, et al. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw. 2018;18(1):e8.
[31] HENRIKSEN K, NEUTZSKY-WULFF AV, BONEWALD LF, et al. Local communication on and within bone controls bone remodeling. Bone. 2009;44(6):1026-1033.
[32] FULLER K, OWENS JM, CHAMBERS TJ. Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J Immunol. 1995;154(11):6065-6072.
[33] LIU X, CHEN Z, LAN T, et al. Upregulation of interleukin-8 and activin A induces osteoclastogenesis in ameloblastoma. Int J Mol Med. 2019;43(6):2329-2340.
[34] THEILL LE, BOYLE WJ, PENNINGER JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795-823.
[35] QUINN JM, ITOH K, UDAGAWA N, et al. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res. 2001; 16(10):1787-1794.
[36] KOPESKY P, TIEDEMANN K, ALKEKHIA D, et al. Millard B, Schoeberl B, Komarova SV. Autocrine signaling is a key regulatory element during osteoclastogenesis. Biol Open. 2014;3(8):767-776.
[37] IGUCHI H, ONO M, MATSUSHIMA K, et al. Overproduction of IL-8 results in suppression of bone metastasis by lung cancer cells in vivo. Int J Oncol. 2000;17(2): 329-333.
[38] SIVARAJ KK, ADAMS RH. Blood vessel formation and function in bone. Development. 2016;143(15):2706-2715.
[39] DENG W, FENG X, LI X, et al. Hypoxia-inducible factor 1 in autoimmune diseases. Cell Immunol. 2016;303:7-15.
[40] WANG Y, WAN C, DENG L, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007; 117(6):1616-1626.
[41] WANG J, WANG Y, WANG S, et al. Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of coloretal cancer. Oncotarget. 2015;6(40):42825-42837.
[42] NIU X, CHEN Y, QI L, et al. Hypoxia regulates angeogenic-osteogenic coupling process via up-regulating IL-6 and IL-8 in human osteoblastic cells through hypoxia-inducible factor-1alpha pathway. Cytokine. 2019;113:117-127.
[43] BAUTCH VL. VEGF-directed blood vessel patterning: from cells to organism. Cold Spring Harb Perspect Med. 2012;2(9):a006452.
[44] HU K, OLSEN BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone. 2016;91:30-38.
[45] HOU Y, RYU CH, JUN JA, et al. IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor. Cell Biol Int. 2014;38(9):1050-1059.
[46] SAITO S, TROVATO MJ, YOU R, et al. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg. 2001;34(5):930-938.
[47] WANG X, KHALIL RA. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Adv Pharmacol. 2018;81:241-330.
[48] CHOU CH, HO CM, LAI S, et al. B-Cell Activating Factor Enhances Hepatocyte-Driven Angiogenesis via B-Cell CLL/Lymphoma 10/Nuclear Factor-KappaB Signaling during Liver Regeneration. Int J Mol Sci. 2019;20(20):5022.
[49] INOUE K, SLATON JW, EVE BY, et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res. 2000; 6(5):2104-2119.
[50] RAIMONDO S, SAIEVA L, VICARIO E, et al. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis. J Hematol Oncol. 2019;12(1):2.
[51] ZHANG Y, ZOU B, TAN Y, et al. Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling. Pharmacol Res. 2019;142:140-150. |